Table 2.

Disposition of [¹⁴C]-radioactivity following oral administration of TBBPA: 25, 250, or 1000 mg/kg at 72 h.

	25 mg/kg, 72 h (N = 4)		250 mg/kg, 72 h (N = 4)		1000 mg/kg, 72 h (N = 4)
	% dose	(nmol-eq/g tissue)	% dose	(nmol-eq/g tissue)	% dose	(nmol-eq/g tissue)
	Mean ± S.D.	(Mean ± S.D.)	Mean ± S.D.	(Mean ± S.D.)	Mean ± S.D.	(Mean ± S.D.)
Large intestine contents	0.02 ± 0.03	(0.5 ± 0.6)	0.02 ± 0.01	(21 ± 32)	0.4 ± 0.3	(241 ± 169)
Small intestine contents	<0.01	(0.07 ± 0.08)	0.01 ± 0.01	(3 ± 3)	0.08 ± 0.06	(63 ± 50)
Liver	0.01 ± 0.002	(0.1 ± 0.01)	0.02 ± 0.01	(2 ± 1)	0.04 ± 0.01	(17 ± 5)
Small intestine	<0.01	(0.05 ± 0.04)	<0.01	(1 ± 1)	0.01 ± 0.01	(14 ± 6)
Muscle	0.02 ± 0.03	(0.02 ± 0.02)	<0.01	(0.2 ± 0.2)	0.03 ± 0.02	(1 ± 0.8)
Skin	0.01 ± 0.01	(0.02 ± 0.02)	<0.01	(3 ± 5)	0.01 ± 0.01	(1 ± 0.7)